Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial

Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Recent versions add and update the Study Status and Contacts/Locations sections, showing new status details and location information.
    Difference
    0.4%
    Check dated 2026-02-19T16:48:46.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A 2026-02-11 version adds/updates the Study Status and Contacts/Locations sections with Revision: v3.4.2; the government funding notice and Revision: v3.4.1 were removed.
    Difference
    0.6%
    Check dated 2026-02-11T14:25:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice is displayed on the page, and the Study Status/version history includes several new entries through 2026-01-31.
    Difference
    0.6%
    Check dated 2026-02-04T10:40:14.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and uses green highlights for additions and red highlights for deletions. The latest revision is listed as v3.4.0 (2026-01-27) and the 'No FEAR Act data' item was removed.
    Difference
    0.7%
    Check dated 2026-01-28T06:23:53.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    New history entries were added (versions 167–170) including updates to Study Status and new Contacts/Locations sections. This expands the official record of changes for the trial.
    Difference
    0.4%
    Check dated 2026-01-21T03:51:52.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added content blocks for Study Status, Contacts/Locations, Eligibility, Outcome Measures, Study Description and Study Identification (versions 165–166) and introduced Revision: v3.3.4. Removed the 2025-12-31 entry and Revision: v3.3.3.
    Difference
    0.3%
    Check dated 2026-01-14T01:57:15.000Z thumbnail image

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.